Overview

Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.

Status:
Suspended
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether N-acetylcysteine is effective in the prophylaxis of post-cardiopulmonary bypass acute renal impairment.
Phase:
Phase 4
Details
Lead Sponsor:
Far Eastern Memorial Hospital
Collaborator:
Synmosa Biopharma Corp.
Treatments:
Acetylcysteine
N-monoacetylcystine